Serum concentration of soluble Fas in patients with autoimmune thyroid diseases

Thyroid

Volumn 8, Issue 1, 1998, Pages 43-47

  Shimaoka, Yuki ^a   Hidaka, Yoh ^a   Okumura, Motoshi ^a   Takeoka, Keiko ^a   Tada, Hisato ^a   Amino, Nobuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; LIOTHYRONINE; MESSENGER RNA; RADIOACTIVE IODINE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; THYROIDITIS;

EID: 0031918574     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.43     Document Type: Article

References (24)

1. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S 1991 The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243.
2. Suda T, Takahashi T, Golstein P, Nagata S 1993 Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
3. Nagata S, Golstein P 1995 The Fas death factor. Science 267:1449-1456.
4. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD 1994 Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759-1762.
5. Papoff G, Cascino I, Eramo A, Starace G, Lynch DH, Ruberti G 1996 An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J Immunol 156:4622-4630.
6. Cascino I, Fiucci G, Papoff G, Ruberti G 1995 Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 154:2706-2713.
7. Liu C, Cheng J, Mountz JD 1995 Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem J 310:957-963.
8. Kotani T, Aratake Y, Hirai K, Fukazawa Y, Sato H, Ohtaki S 1995 Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity 20:231-236.
9. Tanimoto C, Hirakawa S, Kawasaki H, Hayakawa N, Ota Z 1995 Apoptosis in thyroid diseases: a histochemical study. Endocr J 42:193-201.
10. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A 1997 Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963.
11. Seishima M, Takemura M, Saito K, Sano H, Minatoguchi S, Fujiwara H, Hachiya T, Noma A 1996 Highly sensitive ELISA for soluble Fas in serum: increased soluble Fas in the elderly. Clin Chem 42:1911-1914.
12. Okubo M, Ishida H, Kasukawa R 1996 Elevated levels of soluble Fas in systemic lupus erythematosus: Comment on the article by Knipping et al [letter]. Arthritis Rheum 39:1612-1614.
13. Okumura M, Hidaka Y, Kuroda S, Takeoka K, Tada H, Amino N 1997 Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 82:1757-1760.
14. Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K 1987 Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. J Clin Endocrinol Metab 65:324-330.
15. Behrmann I, Walczak H, Krammer PH 1994 Structure of the human APO-1 gene. Eur J Immunol 24:3057-3062.
16. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH 1989 Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305.
17. Watanabe FR, Brannan CI, Copeland NG, Jenkins NA, Nagata S 1992 Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317.
18. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S 1994 Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976.
19. Knipping E, Debatin KM, Stricker K, Heilig B, Eder A, Krammer PH 1995 Identification of soluble APO-1 in supernatants of human B-and T-cell lines and increased serum levels in Band T-cell leukemias. Blood 85:1562-1569.
20. Bogner U, Schleusener H, Wall JR 1984 Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease. J Clin Endocrinol Metab 59:734-738.
21. MacKenzie WA, Schwartz AE, Friedman EW, Davies TF 1987 Intrathyroidal T cell clones from patients with autoimmune thyroid disease. J Clin Endocrinol Metab 64:818-824.
22. Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A 1993 Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77:1700-1705.
23. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Ishikawa N, Ito K, Nagataki S 1996 Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. J Clin Endocrinol Metab 137:3163-3169.
24. Daniel PT, Krammer PH 1994 Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J Immunol 152:5624-5632.